Nav: Home

Study: Bacterium that causes Q fever linked to non-Hodgkin lymphoma

October 13, 2015

(WASHINGTON, October, 13, 2015) -The bacterium that causes Q fever, an infectious disease that humans contract from animals, is associated with an increased risk of lymphoma, according to a study published online today in Blood, the Journal of the American Society of Hematology (ASH).

Q fever is caused by infection with Coxiella burnetii, a bacterium primarily transmitted through the excrement of cattle, sheep, and goats. Approximately 3 percent of healthy adults in the United States and 10-20 percent of those in high-risk occupations such as veterinarians and farmers have antibodies for C. burnetii, suggesting previous infection.1 Symptoms of Q fever vary from person to person and can be acute and resolve spontaneously, or chronic and persistent. Because some patients have been reported to also suffer from lymphoma, researchers believed that this type of cancer could be a risk factor for Q fever. However, the experience of one patient prompted doctors to consider the opposite - that the infection might actually cause the lymphoma.

"During a follow-up scan in a patient we had successfully treated for Q fever, we observed a tumor close to the location of the previous infection," said senior study author Didier Raoult, MD, PhD, of Aix-Marseille University in Marseille, France. "The discovery that it was a lymphoma tumor containing C. burnetii encouraged us to consider that the infection might have contributed to the development of the cancer."

In order to better understand the association between C. burnetii and lymphoma, Dr. Raoult and colleagues screened 1,468 patients treated at the French National Referral Center for Q Fever from 2004 to 2014. Investigators conducted imaging of patient tissue samples to identify seven people, including the initial patient, who developed lymphoma after C. burnetii infection (6 patients were diagnosed with diffuse large B-cell lymphoma and one with follicular lymphoma). Of all the Q fever patients included in the study, 440 presented a persistent infection concentrated to one area.

To determine if patients with Q fever have a higher risk of lymphoma than the general population, researchers compared the incidence of lymphoma in the Q fever registry to the incidence reported in France's general population. Based on this analysis, researchers conclude that patients with Q fever are 25 times more likely to develop diffuse large B-cell lymphoma than those without the infection. In addition, the odds of lymphoma in patients with persistent concentrated infections are higher than those with other forms of Q fever.

Upon further imaging of the patient samples, investigators observed that Q fever patients with lymphoma demonstrate overproduction of the critical anti-inflammatory pathway interleukin-10 (IL-10), suggesting that suppression of the immune system may have allowed the lymphoma cells to evade immune detection and multiply.

"As we continue to learn more about the association between C. burnetii and lymphoma, these results should encourage clinicians to survey high-risk patients as early as possible for potential cancer," said Dr. Raoult. "Ultimately, this early diagnosis and treatment would improve outcomes for Q fever patients who subsequently develop lymphoma, particularly those with B-cell non-Hodgkin lymphoma."
-end-
Blood, the most cited peer-reviewed publication in the field of hematology, is available weekly in print and online. Blood is the official journal of the American Society of Hematology (ASH), the world's largest professional society concerned with the causes and treatment of blood disorders.

ASH's mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology.

blood® is a registered trademark of the American Society of Hematology.

1. [Centers for Disease Control and Prevention; Accessed from: http://www.cdc.gov/qfever/symptoms/index.html (Accessed: 10/2015).]?

American Society of Hematology

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...